Literature DB >> 23836060

Phenotypic CD8+ T cell diversification occurs before, during, and after the first T cell division.

Fabrice Lemaître1, Hélène D Moreau, Laura Vedele, Philippe Bousso.   

Abstract

Effector T cell responses rely on a phenotypically and functionally heterogeneous population of cells. Whether this diversity is programmed before clonal expansion or in later phases as a result of stochastic events or asymmetric cell division is not fully understood. In this study, we first took advantage of a sensitive in vitro assay to analyze the composition of single CD8(+) T cell progenies. Heterogeneity was predominantly observed between progenies of distinct clones, but could also be detected within individual progenies. Furthermore, by physically isolating daughter cells of the first T cell division, we showed that differences in paired daughter cell progenies contributed to intraclonal diversification. Finally, we developed an in vivo limiting dilution assay to compare individual T cell progenies following immunization. We provided evidence for simultaneous intraclonal and interclonal diversification in vivo. Our results support the idea that T cell diversification is a continuous process, initiated before clonal expansion and amplified during the first and subsequent cell divisions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836060     DOI: 10.4049/jimmunol.1300424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Clonal expansion under the microscope: studying lymphocyte activation and differentiation using live-cell imaging.

Authors:  Michal Polonsky; Benjamin Chain; Nir Friedman
Journal:  Immunol Cell Biol       Date:  2015-12-22       Impact factor: 5.126

2.  Generating CD8 T cell heterogeneity: attack of the clones.

Authors:  Heather D Marshall; Susan M Kaech
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

3.  Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation.

Authors:  Ichiko Kinjyo; Jim Qin; Sioh-Yang Tan; Cameron J Wellard; Paulus Mrass; William Ritchie; Atsushi Doi; Lois L Cavanagh; Michio Tomura; Asako Sakaue-Sawano; Osami Kanagawa; Atsushi Miyawaki; Philip D Hodgkin; Wolfgang Weninger
Journal:  Nat Commun       Date:  2015-02-24       Impact factor: 14.919

4.  Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection.

Authors:  Michael M Opata; Robin Stephens
Journal:  Curr Immunol Rev       Date:  2013-08

5.  IL-2 sensitivity and exogenous IL-2 concentration gradient tune the productive contact duration of CD8(+) T cell-APC: a multiscale modeling study.

Authors:  Xuefeng Gao; Christophe Arpin; Jacqueline Marvel; Sotiris A Prokopiou; Olivier Gandrillon; Fabien Crauste
Journal:  BMC Syst Biol       Date:  2016-08-17

6.  Model-Based Assessment of the Role of Uneven Partitioning of Molecular Content on Heterogeneity and Regulation of Differentiation in CD8 T-Cell Immune Responses.

Authors:  Simon Girel; Christophe Arpin; Jacqueline Marvel; Olivier Gandrillon; Fabien Crauste
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

7.  Stochastic asymmetric repartition of lytic machinery in dividing CD8+ T cells generates heterogeneous killing behavior.

Authors:  Fanny Lafouresse; Romain Jugele; Sabina Müller; Marine Doineau; Valérie Duplan-Eche; Eric Espinosa; Marie-Pierre Puisségur; Sébastien Gadat; Salvatore Valitutti
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

Review 8.  T cell fate mapping and lineage tracing technologies probing clonal aspects underlying the generation of CD8 T cell subsets.

Authors:  Shaima Al Khabouri; Carmen Gerlach
Journal:  Scand J Immunol       Date:  2020-10-26       Impact factor: 3.487

Review 9.  Polarized cells, polarized views: asymmetric cell division in hematopoietic cells.

Authors:  Kim Pham; Faruk Sacirbegovic; Sarah M Russell
Journal:  Front Immunol       Date:  2014-02-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.